Linagliptin improved albuminuria but had no effect on eGFR and CV risk in patients with diabetes

In the CARMELINA trial nearly 10% of all patients with diabetes had nephrotic-range proteinuria at baseline. This was associated with a high incidence of cardiovascular/kidney disease but this secondary disease burden could not be lowered by linagliptin. The antidiabetes drug reduced albuminuria and HbA1c in all patients, but did not affect the cardiovascular (CV) risk over 2.2 […]

Continue Reading

Clinical trials and research priorities in dialysis Patients: Time for a new approach?

Historically, the number of RCTs performed in the ESRD population has been very low compared to other medical subspecialties. Furthermore, several of the few large RCTs conducted in patients with ESRD have yielded inconclusive or negative results, dampening enthusiasm for future investment in similar trials. It is therefore important for the Nephrology community to examine […]

Continue Reading

Watch The New Messe Frankfurt Video

Messe Frankfurt expands electromobility on the exhibition grounds. Thanks to the acquisition of three ‘StreetScooter’ electric transport vehicles, it will be possible henceforth to make certain deliveries ‘all-electric’ – with no vehicle emissions whatsoever. As Uwe Behm, Member of the Executive Board of Messe Frankfurt, puts it: “Now, carpeting, signage and even break-time snacks can […]

Continue Reading

The European announces its 2019 awards

The European continues with its annual recognition of excellence across the world of commerce. As the United Nations’ Sustainable Development Goals reshape the corporate agenda, companies are realising that success is measured beyond the balance sheet. Along with product innovation, positive contributions to society and sound stewardship of the environment are becoming the benchmarks by which […]

Continue Reading